Fundamental Analysis of HNR ACQUISITION CORP(NYSEARCA:HNRA) stock

Fundamental Rating

Taking everything into account, HNRA scores 1 out of 10 in our fundamental rating. HNRA was compared to 0 industry peers in the Unkown industry. HNRA may be in some trouble as it scores bad on both profitability and health. HNRA has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year HNRA has reported negative net income.

In the past year HNRA has reported a negative cash flow from operations.

1.2 Ratios

		Industry Rank	Sector Rank
ROA	-0.66%
ROE	-0.79%
ROIC	N/A

ROA(3y)-1.65%

ROA(5y)N/A

ROE(3y)-4.42%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for HNRA so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, HNRA has about the same amount of shares outstanding.

The debt/assets ratio for HNRA has been reduced compared to a year ago.

2.2 Solvency

HNRA has an Altman-Z score of 0.01. This is a bad value and indicates that HNRA is not financially healthy and even has some risk of bankruptcy.

A Debt/Equity ratio of 0.04 indicates that HNRA is not too dependend on debt financing.

		Industry Rank	Sector Rank
Debt/Equity	0.04
Debt/FCF	N/A
Altman-Z	0.01

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 0.12 indicates that HNRA may have some problems paying its short term obligations.

HNRA has a Quick Ratio of 0.12. This is a bad value and indicates that HNRA is not financially healthy enough and could expect problems in meeting its short term obligations.

		Industry Rank	Sector Rank
Current Ratio	0.12
Quick Ratio	0.12

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

HNRA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -5946.61%.

EPS 1Y (TTM)-5946.61%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%100%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

HNRA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 115.22% yearly.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2Y-126.86%

EPS Next 3Y160.73%

EPS Next 5Y115.22%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

HNRA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

HNRA's earnings are expected to grow with 160.73% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-126.86%

EPS Next 3Y160.73%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for HNRA!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

HNR ACQUISITION CORP

NYSEARCA:HNRA (9/17/2024, 8:12:04 PM)

After market: 1.32 +0.13 (+10.92%)

1.19

+0.08 (+7.21%)

Chartmill FA Rating

GICS SectorN/A

GICS IndustryGroupN/A

GICS IndustryN/A

Earnings (Last)08-20 2024-08-20/bmo

Earnings (Next)N/A N/A

Inst Owners1.48%

Inst Owner Change-86.1%

Ins Owners48.26%

Ins Owner Change1.68%

Market Cap6.59M

Analysts82.86

Price Target6.12 (414.29%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-20%

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	0.16
P/tB	0.16
EV/EBITDA	N/A

EPS(TTM)-0.03

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.24

FCFYN/A

OCF(TTM)-0.24

OCFYN/A

SpS0

BVpS7.53

TBVpS7.53

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-0.66%
ROE	-0.79%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-1.65%

ROA(5y)N/A

ROE(3y)-4.42%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0.04
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.12
Quick Ratio	0.12
Altman-Z	0.01

F-Score4

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-5946.61%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%100%

EPS Next YN/A

EPS Next 2Y-126.86%

EPS Next 3Y160.73%

EPS Next 5Y115.22%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-12948%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3Y117.45%

EBIT Next 5Y92.69%

FCF growth 1Y-1419.41%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-1419.41%

OCF growth 3YN/A

OCF growth 5YN/A

HNR ACQUISITION CORP (HNRA)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens